News Column

AMSURG CORP FILES (8-K) Disclosing Other Events, Financial Statements and Exhibits

June 30, 2014

Item 8.01. Other Events.

On June 30, 2014, AmSurg Corp. (the "Company") announced a proposed offering of approximately $880 million aggregate principal amount of its senior unsecured notes due 2022 (the "Notes"). The closing of the offering of the Notes is conditioned upon the closing of the Company's previously announced acquisition of Sheridan Healthcare.

The Notes will be offered in the United States only to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and outside the United States to non-U.S. persons pursuant to Regulation S under the Securities Act.

The foregoing is qualified by reference to the press release that is attached as Exhibit 99.1 to this Current Report on Form 8-K, which is incorporated herein by reference.

This Current Report on Form 8-K, including the press release filed as Exhibit 99.1, does not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any offer, solicitation or sale of these securities in any state in which such offer, solicitation or sale would be unlawful. These securities will not be registered under the Securities Act or any state securities laws and, unless so registered, may not be offered or sold in the United States except pursuant to an exemption from the registration requirements of the Securities Act and applicable state laws.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits. 99.1 Press release of AmSurg Corp. issued on June 30, 2014. 2


For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: Edgar Glimpses

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters